• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC ID: Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003?2013

tetano

Editor, Senior Moderator
[h=1]Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003?2013[/h] Anne Mosnier[SUP]1[/SUP][SUP]2[/SUP][SUP]*[/SUP], Saverio Caini[SUP]1[/SUP], Isabelle Daviaud[SUP]1[/SUP][SUP]2[/SUP], Jean-Louis Bensoussan[SUP]2[/SUP], Fran?oise Stoll-Keller[SUP]3[/SUP], Tan Tai Bui[SUP]1[/SUP], Bruno Lina[SUP]4[/SUP], Sylvie Van der Werf[SUP]5[/SUP], Jean Marie Cohen[SUP]1[/SUP][SUP]2[/SUP] and on behalf of the GROG network
Author Affiliations
[SUP]1[/SUP] Open Rome (Organize and Promote Epidemiological Network), 67 rue du Poteau, Paris, 75018, France
[SUP]2[/SUP] R?seau des GROG, 67 rue du Poteau, Paris, 75018, France
[SUP]3[/SUP] Laboratoire de Virologie, CHU de Strasbourg, Strasbourg, France
[SUP]4[/SUP] CNR des virus influenzae, CBPE, HCL & Virpath, UCBL, Universit? de Lyon, Lyon, France
[SUP]5[/SUP] CNR des virus influenzae, GMVR Institut Pasteur, CNRS UMR3569, Universit? Paris Diderot, Sorbonne Paris Cit?, Paris, France

For all author emails, please log on.





BMC Infectious Diseases 2015, 15:357 doi:10.1186/s12879-015-1056-z
Published: 21 August 2015
[h=3]Abstract[/h] [h=4]Background[/h] Describing the circulation of influenza viruses and the characteristics of seasonal epidemics remains an essential tool to optimize the strategies of influenza prevention and control. Special attention has been recently paid to influenza B in the context of the availability of a quadrivalent vaccine, containing two influenza B strains.
[h=4]Methods[/h] We used data from a practitioners-based influenza surveillance network to describe the circulation of influenza viruses in France from 2003?2004 to 2012?2013. Nasopharyngeal swabs taken from acute respiratory infection (ARI) patients between October and April were tested for influenza. We reported the number of influenza cases by virus type (A, B), subtype (A(H1), A(H3)) and B lineage (Yamagata, Victoria) in each season and determined the frequency of influenza B vaccine mismatch. We estimated weekly incidence of influenza by extrapolating reported influenza cases to the French population. We compared the temporal characteristics of the epidemics caused by influenza A(H1), A(H3) and B.
[h=4]Results[/h] Overall, 49,919 ARI patients were tested, of which 16,287 (32.6 %) were positive for influenza. Type B virus caused 23.7 % of all influenza cases. Virus subtypes A(H1) and A(H3) caused 51.6 % and 48.4 % of influenza A cases, respectively. Viruses of the B-Yamagata and B-Victoria lineage caused 62.8 % and 37.2 % of influenza B cases, respectively. There was an influenza B vaccine mismatch in three of the five seasons where influenza B caused 10 % or more of all influenza cases. Influenza A(H3) had the highest average value of estimated weekly incidence during the study period. Influenza B peaked an average 3.8 weeks later than influenza A when both virus types were circulating. No differences in the duration of influenza A and B epidemics were observed.
[h=4]Conclusions[/h] Influenza A(H3) was the most prevalent influenza type during the study period. Influenza B caused around one fourth of all influenza cases and tended to circulate later than influenza A. The frequency of influenza B vaccine mismatches was substantial. Timely data on the circulation of influenza viruses collected within influenza surveillance systems are essential to optimize influenza prevention and control strategies.
[h=5]Keywords:[/h] Influenza surveillance; Influenza virus type A; Influenza virus type B; Influenza vaccine match; Influenza incidence; Timing of influenza epidemics

open access

http://www.biomedcentral.com/1471-2334/15/357
 
Back
Top Bottom